Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Lymphoma

Free Subscription 07.07.2025 2 Am J Clin Pathol 1 Am J Hematol 1 Am J Surg Pathol 1 BMC Cancer 1 BMC Neurol 1 Bone Marrow Transplant 4 Br J Haematol 1 Eur J Haematol 3 Haematologica 1 Int J Radiat Oncol Biol Phys 1 J Natl Cancer Inst 3 Leuk Lymphoma 1 Leukemia 1 Oncol Rep 1 Oncology (Williston Park)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Clin Pathol

1. BHATTARAI N, Cook JR
   IRTA1 expression in extranodal marginal zone (MALT) lymphoma is variable across anatomic sites.
   Am J Clin Pathol. 2025 Jun 30:aqaf056. doi: 10.1093.
   PubMed         Abstract available
   
   
2. GISRIEL SD, Yuan J, Tang H, Xu J, et al
   Concurrent or subsequent lymphomatous effusion in large B-cell lymphoma portends a dismal prognosis: A multi-institutional study.
   Am J Clin Pathol. 2025 Jun 29:aqaf057. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Hematol

3. LOSSOS IS, Jiang X, Patel K, Moalem KN, et al
   Association Between Moraxella catarrhalis and Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
   Am J Hematol. 2025 Jul 4. doi: 10.1002/ajh.27762.
   PubMed         Abstract available
   
   

   
   Am J Surg Pathol

4. DE CASTRO JVA, Kim J, Tyagi M, Xi L, et al
   Genomics of T-Cell Lymphomas With CD30/CD15 Co-Expression: Comparison With Anaplastic Large-Cell Lymphoma, ALK-Negative.
   Am J Surg Pathol. 2025 Jul 3. doi: 10.1097/PAS.0000000000002447.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. WANG X, Li Z, Chang Y, Li S, et al
   Early assessment of therapeutic efficacy in lymphoma patients via a blood-based multi-omics response monitoring test.
   BMC Cancer. 2025;25:1078.
   PubMed         Abstract available
   
   

   
   BMC Neurol

6. ZHANG Z, Ling C, Zhang Y, Sun W, et al
   Clinically probable paraneoplastic vasculitic peripheral neuropathy in primary central nervous system lymphoma: a case report.
   BMC Neurol. 2025;25:252.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

7. BEKADJA MA, Niederwieser D, Kharfan-Dabaja MA, El Fakih R, et al
   Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation.
   Bone Marrow Transplant. 2025 Jun 30. doi: 10.1038/s41409-025-02664.
   PubMed        
   
   

   
   Br J Haematol

8. ALZAHRANI M, Gerrie AS, Sehn LH, Scott DW, et al
   Therapeutic advances and gradual improvement in overall survival in mantle cell lymphoma over four decades.
   Br J Haematol. 2025 Jul 2. doi: 10.1111/bjh.20239.
   PubMed        
   
   
9. GASCON P, Frankel D, Fritz S, Comet A, et al
   Vitrectomy as a rapid diagnostic tool for lymphoma: Cytology and flow cytometry approach.
   Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20250.
   PubMed        
   
   
10. CASSANELLO G, Luttwak E, Brown S, Devlin SM, et al
    Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.
    Br J Haematol. 2025 Jul 1. doi: 10.1111/bjh.20234.
    PubMed         Abstract available
    
    
11. SHARP J, Zhao Q, Voorhees TJ, Bond DA, et al
    Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphoma.
    Br J Haematol. 2025 Jun 30. doi: 10.1111/bjh.20240.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

12. ZHU M, Li T, Han S, Zhao D, et al
    Construction of Lymphoma Organoids and Applications in Tumor Microenvironment Research.
    Eur J Haematol. 2025 Jun 30. doi: 10.1111/ejh.14448.
    PubMed         Abstract available
    
    

    
    Haematologica

13. SHOUSE G, Chen C, Muir A, Popplewell L, et al
    Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter's transformation or transformed non-Hodgkin lymphoma: results from a phase I trial.
    Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2024.286945.
    PubMed         Abstract available
    
    
14. DANILOV AV, Li H, Shadman M, Rimsza L, et al
    Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemo-immunotherapy on the SWOG S0016 trial.
    Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2025.288057.
    PubMed         Abstract available
    
    
15. DOGLIOTTI I, Federico M
    BTKi +humanized anti-CD20 for advanced follicular lymphoma: ready for an ALTERNATIVE?
    Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2025.288196.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

16. HOPPE BS, Mailhot-Vega RB, Renfro LA, Pei Q, et al
    Comparison of Contemporary Radiotherapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331.
    Int J Radiat Oncol Biol Phys. 2025 Jun 28:S0360-3016(25)04518.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

17. GANGARAJU R, Chen Y, Hageman L, Bosworth A, et al
    Clonal hematopoiesis and subsequent venous thromboembolism among survivors of autologous transplantation for lymphoma.
    J Natl Cancer Inst. 2025 Jul 2:djaf164. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

18. DERENZINI E, Gibb A, Kwiatek M, Strati P, et al
    Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events.
    Leuk Lymphoma. 2025 Jun 30:1-13. doi: 10.1080/10428194.2025.2520440.
    PubMed         Abstract available
    
    
19. MAURER K, Jacobson CA
    T-cell neoplasias and secondary malignancies after CAR-T cell therapy: current knowledge, risk factors, and implications from CAR-T engineering strategies.
    Leuk Lymphoma. 2025;66:1189-1197.
    PubMed         Abstract available
    
    
20. LUTTWAK E, Robin ET, Drill E, Boardman A, et al
    Outcomes of T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era: insights from a retrospective analysis.
    Leuk Lymphoma. 2025;66:1276-1283.
    PubMed         Abstract available
    
    

    
    Leukemia

21. MIELAND AO, Petrosino G, Dejung M, Chen JX, et al
    The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.
    Leukemia. 2025;39:1756-1768.
    PubMed         Abstract available
    
    

    
    Oncol Rep

22. LIU Q, Ling J, Li Z, Bi L, et al
    Advances in lymphoma biomarkers research based on proteomics technology (Review).
    Oncol Rep. 2025;54:108.
    PubMed         Abstract available
    
    

    
    Oncology (Williston Park)

23. HAO-YU D, Yi-Wei C, Shao-Ke L, Dong-Liang L, et al
    Extranodal NK/T-Cell Lymphoma Misdiagnosed as Pulmonary Infection.
    Oncology (Williston Park). 2025;null:198-203.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.